GlobalData on MSN3d
Trevi’s Phase IIb chronic cough success spikes stock by 71%The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
Beckley Psytech has completed subject enrolment for the core stage of the global Phase IIb clinical trial of patent-protected ...
The Phase IIa study REIMAGINE evaluated the safety and ... further clinical development in BPD After an informative Phase IIb in BPD and FDA EoPII meeting, preparations for the PORTICO-2 Phase ...
The Phase Ib and Phase IIa studies showed a good safety and tolerability ... effect compared with current treatment options. A Phase IIb study, completed in 2023, showed that mesdopetam has ...
The Phase Ib and Phase IIa studies showed a good safety and tolerability ... effect compared with current treatment options. A Phase IIb study, completed in 2023, showed that mesdopetam has ...
Beyond BPD, vafidemstat is being evaluated in a Phase IIb trial for the treatment of negative symptoms in schizophrenia (EVOLUTION trial) and is part of Oryzon’s broader CNS precision medicine ...
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III ...
GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB , a company discovering and developing novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback